We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCAB icon
2601
BioAtla
BCAB
$5.64M
$78.1K ﹤0.01%
80
RDUS
2602
DELISTED
Radius Health, Inc.
RDUS
$77.4K ﹤0.01%
11,188
-60
-0.5% -$880
OIS icon
2603
Oil States International
OIS
$531M
$77.3K ﹤0.01%
15,556
-1,394
-8% -$8.21K
ALGS icon
2604
Aligos Therapeutics
ALGS
$42.3M
$77.2K ﹤0.01%
260
CCRD
2605
DELISTED
CoreCard
CCRD
$76.8K ﹤0.01%
1,980
HOFT icon
2606
Hooker Furnishings Corp
HOFT
$159M
$76.6K ﹤0.01%
3,289
-874
-21% -$22K
XXII
2607
22nd Century Group
XXII
$1.42M
0
ORRF icon
2608
Orrstown Financial Services
ORRF
$850M
$75.9K ﹤0.01%
3,013
ALTG icon
2609
Alta Equipment Group
ALTG
$235M
$75.8K ﹤0.01%
5,176
-151
-3% -$2.22K
RPT
2610
Rithm Property Trust
RPT
$101M
$75.5K ﹤0.01%
956
-35
-4% -$2.86K
LBRDA icon
2611
Liberty Broadband Class A
LBRDA
$5.29B
$75.3K ﹤0.01%
468
-25
-5% -$4.05K
RYTM icon
2612
Rhythm Pharmaceuticals
RYTM
$8.21B
$75.2K ﹤0.01%
7,534
-1,259
-14% -$14.1K
EYPT icon
2613
EyePoint Inc
EYPT
$1.15B
$74.9K ﹤0.01%
+6,122
New +$82.4K
BYRN icon
2614
Byrna Technologies
BYRN
$97.8M
$74.8K ﹤0.01%
5,603
FSLY icon
2615
Fastly Inc
FSLY
$4.75B
$74.7K ﹤0.01%
2,108
+6
+0.3% +$261
ABUS icon
2616
Arbutus Biopharma
ABUS
$892M
$74.4K ﹤0.01%
19,131
-3,597
-16% -$14K
UVE icon
2617
Universal Insurance Holdings
UVE
$1.19B
$74.3K ﹤0.01%
4,368
-2,567
-37% -$38.8K
LOCO icon
2618
El Pollo Loco
LOCO
$467M
$74.2K ﹤0.01%
5,232
-430
-8% -$6.29K
CURO
2619
DELISTED
CURO Group Holdings Corp.
CURO
$73.4K ﹤0.01%
4,584
-1,748
-28% -$30.4K
DZSI
2620
DELISTED
DZS Inc. Common Stock
DZSI
$73.3K ﹤0.01%
+4,516
New +$59.9K
QNCX icon
2621
Quince Therapeutics
QNCX
$34.1M
$73.1K ﹤0.01%
29
+3
+12% +$18.3K
NRIM icon
2622
Northrim BanCorp
NRIM
$603M
$73K ﹤0.01%
6,716
MRNS
2623
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$72.7K ﹤0.01%
6,120
-667
-10% -$7.7K
VOR icon
2624
Vor Biopharma
VOR
$1.36B
$72.7K ﹤0.01%
313
USLM icon
2625
United States Lime & Minerals
USLM
$3.4B
$72.6K ﹤0.01%
2,815

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.